BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32202952)

  • 1. Evaluation of changing the pattern of CTRP5 and inflammatory markers levels in patients with coronary artery disease and type 2 diabetes mellitus.
    Moradi N; Fadaei R; Rashidbeygi E; Bagheri Kargasheh F; Malek M; Shokoohi Nahrkhalaji A; Fallah S
    Arch Physiol Biochem; 2022 Aug; 128(4):964-969. PubMed ID: 32202952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum C1q-tumour necrosis factor-related protein 5 levels with metabolic parameters and carotid intima-media thickness in newly diagnosed type 2 diabetes mellitus patients.
    Uçar İMB; Çalan M; Tatar E; Chousein R; Fenercioğlu ÖE; Bozkaya G; Yüksel A
    Hormones (Athens); 2020 Dec; 19(4):559-564. PubMed ID: 32594414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
    Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
    PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein signature of coronary artery disease in type 2 diabetes mellitus.
    Adela R; Reddy PNC; Ghosh TS; Aggarwal S; Yadav AK; Das B; Banerjee SK
    J Transl Med; 2019 Jan; 17(1):17. PubMed ID: 30674322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.
    Fadaei R; Moradi N; Baratchian M; Aghajani H; Malek M; Fazaeli AA; Fallah S
    PLoS One; 2016; 11(12):e0168773. PubMed ID: 28033351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis.
    Li C; Chen JW; Liu ZH; Shen Y; Ding FH; Gu G; Liu J; Qiu JP; Gao J; Zhang RY; Shen WF; Wang XQ; Lu L
    Atherosclerosis; 2018 Nov; 278():197-209. PubMed ID: 30300788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.
    Antoniades C; Tousoulis D; Marinou K; Papageorgiou N; Bosinakou E; Tsioufis C; Stefanadi E; Latsios G; Tentolouris C; Siasos G; Stefanadis C
    Clin Cardiol; 2007 Jun; 30(6):295-300. PubMed ID: 17551966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease.
    Moradi N; Fadaei R; Emamgholipour S; Kazemian E; Panahi G; Vahedi S; Saed L; Fallah S
    PLoS One; 2018; 13(1):e0192159. PubMed ID: 29381773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study.
    Emamgholipour S; Moradi N; Beigy M; Shabani P; Fadaei R; Poustchi H; Doosti M
    Diabetol Metab Syndr; 2015; 7():108. PubMed ID: 26613006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between vaspin level and coronary artery disease in patients with type 2 diabetes.
    Hao F; Zhang H; Zhu J; Kuang H; Yu Q; Bai M; Mu J
    Diabetes Res Clin Pract; 2016 Mar; 113():26-32. PubMed ID: 26972957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance.
    Fadaei R; Moradi N; Kazemi T; Chamani E; Azdaki N; Moezibady SA; Shahmohamadnejad S; Fallah S
    Cytokine; 2019 Jan; 113():326-331. PubMed ID: 30337217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery.
    Hocker JR; Lerner M; Lightfoot SA; Peyton MD; Thompson JL; Deb S; Reinersman M; Hanas RJ; Postier RG; Edil BH; Burkhart HM; Hanas JS
    PLoS One; 2020; 15(8):e0234539. PubMed ID: 32756554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower Expression of miR-10a in Coronary Artery Disease and its Association with Pro/Anti-Inflammatory Cytokines.
    Moradi N; Fadaei R; Ahmadi R; Kazemian E; Fallah S
    Clin Lab; 2018 May; 64(5):847-854. PubMed ID: 29739060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females.
    Ahmed SF; Shabayek MI; Abdel Ghany ME; El-Hefnawy MH; El-Mesallamy HO
    PLoS One; 2018; 13(12):e0208038. PubMed ID: 30557342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum S100A12 levels are correlated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhao P; Wu M; Yu H; Huang Y; Wang Y; Wang W; Yin W
    J Investig Med; 2013 Jun; 61(5):861-6. PubMed ID: 23609464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
    Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
    Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease.
    Madhumitha H; Mohan V; Deepa M; Babu S; Aravindhan V
    Cardiovasc Diabetol; 2014 Jan; 13():1. PubMed ID: 24383855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells.
    Shen Y; Li C; Zhang RY; Zhang Q; Shen WF; Ding FH; Lu L
    Int J Cardiol; 2017 Feb; 228():129-136. PubMed ID: 27863353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus.
    Kim HM; Lee BW; Song YM; Kim WJ; Chang HJ; Choi DH; Yu HT; Kang E; Cha BS; Lee HC
    Cardiovasc Diabetol; 2012 Jul; 11():84. PubMed ID: 22809439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of C1q/TNF-related protein superfamily in patients with coronary artery disease.
    Zhang Y; Liu C; Liu J; Guo R; Yan Z; Liu W; Lau WB; Jiao X; Cao J; Xu K; Jia Y; Ma X; Wang Y
    Sci Rep; 2020 Jan; 10(1):878. PubMed ID: 31965030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.